JP2011507915A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507915A5
JP2011507915A5 JP2010540046A JP2010540046A JP2011507915A5 JP 2011507915 A5 JP2011507915 A5 JP 2011507915A5 JP 2010540046 A JP2010540046 A JP 2010540046A JP 2010540046 A JP2010540046 A JP 2010540046A JP 2011507915 A5 JP2011507915 A5 JP 2011507915A5
Authority
JP
Japan
Prior art keywords
oxo
phenyl
ethoxy
carbonyl
pyrazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010540046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507915A (ja
JP5504171B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/010572 external-priority patent/WO2009080226A2/en
Publication of JP2011507915A publication Critical patent/JP2011507915A/ja
Publication of JP2011507915A5 publication Critical patent/JP2011507915A5/ja
Application granted granted Critical
Publication of JP5504171B2 publication Critical patent/JP5504171B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010540046A 2007-12-26 2008-12-12 P2y12アンタゴニストとしてのヘテロサイクリックピラゾール−カルボキサミド Expired - Fee Related JP5504171B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07291627 2007-12-26
EP07291627.3 2007-12-26
PCT/EP2008/010572 WO2009080226A2 (en) 2007-12-26 2008-12-12 Heterocyclic pyrazole-carboxamides as p2y12 antagonists

Publications (3)

Publication Number Publication Date
JP2011507915A JP2011507915A (ja) 2011-03-10
JP2011507915A5 true JP2011507915A5 (enExample) 2012-02-02
JP5504171B2 JP5504171B2 (ja) 2014-05-28

Family

ID=39521970

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010540046A Expired - Fee Related JP5504171B2 (ja) 2007-12-26 2008-12-12 P2y12アンタゴニストとしてのヘテロサイクリックピラゾール−カルボキサミド

Country Status (4)

Country Link
US (1) US8426420B2 (enExample)
EP (1) EP2238128B1 (enExample)
JP (1) JP5504171B2 (enExample)
WO (1) WO2009080226A2 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4729133B2 (ja) 2007-11-29 2011-07-20 アクテリオン ファーマシューティカルズ リミテッド ホスホン酸誘導体及びp2y12受容体拮抗剤としてのそれらの使用
AR071653A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2-fenil-4-ciclopropil-pirimidina
AR071652A1 (es) 2008-04-11 2010-07-07 Actelion Pharmaceuticals Ltd Derivados 2- fenil-piridina substituidos
CA2756542C (en) 2009-04-08 2017-08-22 Actelion Pharmaceuticals Ltd 6-(3-aza-bicyclo[3.1.0]hex-3-yl)-2-phenyl-pyrimidines
CA2756654C (en) 2009-04-22 2017-08-22 Actelion Pharmaceuticals Ltd Thiazole derivatives and their use as p2y12 receptor antagonists
AR079967A1 (es) 2010-01-26 2012-02-29 Sanofi Aventis Derivados de acido 3-heteroaroilamino-propionico sustituidos con oxigeno y su uso como productos farmaceuticos
TWI523844B (zh) 2011-01-26 2016-03-01 賽諾菲公司 經胺基取代之3-雜芳醯基胺基-丙酸衍生物及其作為藥物之用途
US8669370B2 (en) 2011-01-26 2014-03-11 Sanofi Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
FR2974576B1 (fr) * 2011-04-29 2013-07-19 Sanofi Aventis Derives de n-[(1h-pyrazol-1-yl)aryl]-1h-indole ou 1h- indazole-3-carboxamide, leur preparation et leurs applications en therapeutique
KR20140049020A (ko) 2011-07-26 2014-04-24 사노피 치환된 3-(티아졸-4-카보닐)- 또는 3-(티아졸-2-카보닐)아미노프로피온산 유도체 및 이의 약제로서의 용도
ES2560381T3 (es) 2011-07-26 2016-02-18 Sanofi Derivados de ácido 3-heteroaroilamino-propiónico y su uso como productos farmacéuticos
WO2013033178A1 (en) 2011-08-30 2013-03-07 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus
WO2013072328A1 (en) 2011-11-14 2013-05-23 Sanofi Use of telaprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases
WO2013072327A1 (en) 2011-11-14 2013-05-23 Sanofi Use of boceprevir and related compounds in atherosclerosis, heart failure, renal diseases, liver diseases or inflammatory diseases
US9409895B2 (en) 2012-12-19 2016-08-09 Novartis Ag Autotaxin inhibitors
ES2715682T3 (es) 2012-12-19 2019-06-05 Novartis Ag Inhibidores de la autotaxina
CN105051038B (zh) 2013-03-28 2018-08-03 赛诺菲 联芳基-丙酸衍生物及其作为药物的用途
EP2978747B1 (en) 2013-03-28 2017-04-19 Sanofi Biaryl-propionic acid derivatives and their use as pharmaceuticals
CN104109158A (zh) * 2013-04-16 2014-10-22 上海医药工业研究院 一种纯化利伐沙班的方法
EP2805705B1 (en) 2013-05-23 2016-11-09 IP Gesellschaft für Management mbH Packaging with one or more administration units comprising a sodium salt of (R)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1 H-imidazol-4-yl)-propionic acid
CN104418938B (zh) * 2013-08-28 2018-05-18 北京赛而生物药业有限公司 一种抗凝血化合物、其制备方法和用途、及包含其的药物组合物
US9231217B2 (en) * 2013-11-28 2016-01-05 Semiconductor Energy Laboratory Co., Ltd. Synthesis method of organometallic complex, synthesis method of pyrazine derivative, 5,6-diaryl-2-pyrazyl triflate, light-emitting element, light-emitting device, electronic device, and lighting device
DK3515924T3 (da) 2016-09-22 2022-03-21 Idorsia Pharmaceuticals Ltd Krystallinske former
SG11201908128YA (en) 2017-03-15 2019-10-30 Idorsia Pharmaceuticals Ltd Subcutaneous administration of a p2y12 receptor antagonist
US12396970B2 (en) 2021-08-20 2025-08-26 AltaThera Pharmaceuticals LLC Anti-arrhythmic compositions and methods
US11344518B2 (en) 2018-08-14 2022-05-31 AltaThera Pharmaceuticals LLC Method of converting atrial fibrillation to normal sinus rhythm and loading oral sotalol in a shortened time frame
US11696902B2 (en) 2018-08-14 2023-07-11 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
US11610660B1 (en) 2021-08-20 2023-03-21 AltaThera Pharmaceuticals LLC Antiarrhythmic drug dosing methods, medical devices, and systems
US10512620B1 (en) 2018-08-14 2019-12-24 AltaThera Pharmaceuticals, LLC Method of initiating and escalating sotalol hydrochloride dosing
WO2021201036A1 (ja) 2020-03-31 2021-10-07 田辺三菱製薬株式会社 ヒドロキシピロリジン誘導体およびその医薬用途
CN115429874A (zh) * 2022-09-20 2022-12-06 暨南大学 水蛭素靶向并抑制dpp4治疗糖尿病
CN119930579A (zh) * 2025-01-15 2025-05-06 四川轻化工大学 哌啶环类化合物及其合成方法、药学上可接受的盐与应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612359A (en) 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
US5621359A (en) * 1995-07-27 1997-04-15 Lucent Technologies Inc. Gain selection technique
TW536540B (en) 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
PE121699A1 (es) 1997-02-18 1999-12-08 Boehringer Ingelheim Pharma Heterociclos biciclicos disustituidos como inhibidores de la trombina
ZA985247B (en) 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
ATE416772T1 (de) 1998-07-06 2008-12-15 Bristol Myers Squibb Co Biphenylsulfonamide als zweifach aktive rezeptor antagonisten von angiotensin und endothelin
US6548529B1 (en) 1999-04-05 2003-04-15 Bristol-Myers Squibb Company Heterocyclic containing biphenyl aP2 inhibitors and method
CA2383008A1 (en) 1999-06-14 2000-12-21 Amanda Jane Lyons Compounds
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
AR035216A1 (es) 2000-12-01 2004-05-05 Astrazeneca Ab Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios
US6861424B2 (en) * 2001-06-06 2005-03-01 Schering Aktiengesellschaft Platelet adenosine diphosphate receptor antagonists
CN110894196A (zh) 2001-09-21 2020-03-20 百时美-施贵宝控股爱尔兰无限公司 含有内酰胺的化合物及其衍生物作为Xa因子的抑制剂
BR0317659A (pt) * 2002-12-23 2005-12-06 Aventis Pharma Gmbh Derivados de pirazol como inibidores de fator xa
GB0309637D0 (en) * 2003-04-28 2003-06-04 Cancer Rec Tech Ltd Pyrazole compounds
AU2003249865A1 (en) 2003-06-24 2005-01-21 Actelion Pharmaceuticals Ltd Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors
TW200526641A (en) * 2003-12-26 2005-08-16 Daiichi Seiyaku Co Amidopyrazole derivatives
US7441581B2 (en) * 2005-03-10 2008-10-28 3M Innovative Properties Company Adhesive tape applicator
TW200640877A (en) * 2005-04-28 2006-12-01 Actelion Pharmaceuticals Ltd Pyrimidine derivatives

Similar Documents

Publication Publication Date Title
JP2011507915A5 (enExample)
US6627629B2 (en) N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
TWI409261B (zh) 經取代之苯甲醯胺衍生物
JP2006528940A5 (enExample)
JP2010539152A5 (enExample)
DE602004006431D1 (de) Derivate von n-äheteroaryl(piperidin-2-yl)methylübenzamid, verfahren zu deren herstellung und deren anwendung in therapeutika
JP2016536333A5 (enExample)
ES2505190T3 (es) Derivados de piperidina como antagosistas del receptor nk3
CN1523986A (zh) 用于联合治疗的取代的噁唑烷酮类化合物
CN1893945A (zh) 作为趋化因子受体调控剂的3-环烷基氨基吡咯烷衍生物
CN1384830A (zh) 用作半胱氨酸蛋白酶的可逆抑制剂的新颖螺旋杂环化合物
RU2013157374A (ru) Производное индазола и пирролопиридина и его фармацевтическое применение
RU2010106974A (ru) Ариловые эфиры пирролидина в качестве антагонистов рецепторов nk3
CA2623043A1 (en) Isoxazolo derivatives as gaba a alpha5 inverse agonists
CN1419541A (zh) 作为bax抑制剂的药物活性的吡咯烷衍生物
JP2014133739A5 (enExample)
JP5677457B2 (ja) ピロリジン誘導体
RU2008149927A (ru) Производные 1-[(4-[ензоил(метил)амино]-3-(фенил)бутил]азетидина для лечения желудочно-кишечных расстройств
RU2014136573A (ru) Новые производные пирролидина
RU2561271C2 (ru) Производные пирролидина в качестве антагонистов рецептора nk-3
CA2449578A1 (en) Pyrrolidine oxadiazole- and thiadiazole derivatives
RU2006100730A (ru) Цис-2, 4, 5-триарил-имидазолины
RU2664644C2 (ru) Новые производные тетразолона
JP2010530380A5 (enExample)
AU2010215513A1 (en) Pyrrolidine derivatives as NK3 receptor antagonists